A detailed history of Great Lakes Advisors, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 114,560 shares of GKOS stock, worth $17.9 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
114,560
Previous 117,656 2.63%
Holding current value
$17.9 Million
Previous $13.9 Million 7.18%
% of portfolio
0.13%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$113.62 - $135.39 $351,767 - $419,167
-3,096 Reduced 2.63%
114,560 $14.9 Million
Q2 2024

Aug 05, 2024

BUY
$89.48 - $118.35 $10.5 Million - $13.9 Million
117,656 New
117,656 $13.9 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.44B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.